|
CBLB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.84319999660698E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65090000003865E-06 |
| Normal-vs-Stage2 |
5.099600E-03 |
| Normal-vs-Stage3 |
1.463800E-01 |
| Normal-vs-Stage4 |
7.871800E-01 |
| Stage1-vs-Stage2 |
6.483600E-01 |
| Stage1-vs-Stage3 |
1.402220E-01 |
| Stage1-vs-Stage4 |
3.162100E-03 |
| Stage2-vs-Stage3 |
3.242400E-01 |
| Stage2-vs-Stage4 |
2.614200E-02 |
| Stage3-vs-Stage4 |
2.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24499999976102E-07 |
| Normal-vs-AfricanAmerican |
4.164100E-03 |
| Normal-vs-Asian |
3.437800E-01 |
| Caucasian-vs-AfricanAmerican |
1.987360E-01 |
| Caucasian-vs-Asian |
6.126800E-01 |
| AfricanAmerican-vs-Asian |
9.398800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.49309997277936E-09 |
| Normal-vs-Female |
4.703100E-03 |
| Male-vs-Female |
6.459700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.830200E-02 |
| Normal-vs-Extreme_Weight |
4.30049999999849E-05 |
| Normal-vs-Obese |
1.371600E-04 |
| Normal-vs-Extreme_Obese |
5.329400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.572100E-02 |
| Normal_Weight-vs-Obese |
5.001600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.254400E-01 |
| Extreme_Weight-vs-Obese |
7.449000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.225800E-01 |
| Obese-vs-Extreme_Obese |
2.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.367000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.03520000016566E-07 |
| Normal-vs-Age(61-80Yrs) |
3.91969999999908E-05 |
| Normal-vs-Age(81-100Yrs) |
6.079200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.747600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.059600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.592010E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.051800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.542400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.395000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8806000090521E-09 |
| Normal-VS-Type2 PRCC |
4.648800E-01 |
| Normal-VS-KIRP CIMP |
1.955200E-04 |
| Normal-VS-Unclassified PRCC |
3.449400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.36350000000418E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.394200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.733600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.820100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.002500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.000800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.982000E-02 |
| Normal-vs-N1 |
1.024030E-02 |
| Normal-vs-N2 |
7.172400E-01 |
| N0-vs-N1 |
3.081400E-01 |
| N0-vs-N2 |
3.627800E-01 |
| N1-vs-N2 |
1.847350E-01 |
|
|
